EHMT2 and neoplasm: Furthermore, consistent with strong tumor suppression, we noted reduced Ki-67 staining in EMT6 tumors expressing Ehmt2 compared to those expressing NS shRNA from immunocompetent syngeneic BALB/c mice (Fig. EV5E,F).